Uromigos-Microbiome

Advertisement
The UromigosThe Uromigos | November 11, 2022
Nazli Dizman covers an update on the CBM588 probiotic strain and its phase II trial.
Listen Now
The UromigosThe Uromigos | December 17, 2021
Tom and Brian take a look back at the year in kidney cancer with Dr. Toni Choueiri.
The UromigosThe Uromigos | September 21, 2022
The Uromigos and Monty Pal discuss data on microbiome modification's impact on immune-oncology clinical efficacy in mRCC.
Advertisement
Advertisement
Advertisement